Douglas Losordo
Principal investigator, leads NeoStem, Inc..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$1.9MFederal grants as PI1 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
1 awards · $1.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 20, 2017 | NIH | SBIR Phase II Exploratory Clinical Study to Evaluate the Potential Bioactivity of CLBS14 in Patients with Coronary Microvascular Dysfunction | $1.9M | NeoStem, Inc. |
Peer ranks
Federal funding#1,099
Awards as PI#2,176
Patents#273
Companies
- NeoStem, Inc.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.